Merus’ $173M Follow-On Offering of Common Shares

NautaDutilh and Latham & Watkins advised Merus N.V. on its offering.Merus N.V., a clinical-stage oncology company, has successfully raised around USD 173 million through an underwritten…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Georgio Naffaa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here